Brookfield Reinsurance (NYSE:BNRE) Hits New 52-Week High - Still a Buy?

Brookfield Reinsurance Ltd. (NYSE:BNRE) reached a new 52-week high during trading on Monday. The stock surged to $54.73 before settling at $54.59, with a trading volume of 5,135 shares. This marked a significant increase from its previous closing price of $53.40.

Stock Performance Overview

Brookfield Reinsurance's market capitalization stands at $7.94 billion. The stock currently has a price-to-earnings (P/E) ratio of 184.14, indicating the price investors are willing to pay relative to each dollar of earnings. The stock exhibits a beta of 1.53, suggesting it is more volatile than the broader market.

As for its moving averages, the 50-day simple moving average is $50.69, while the 200-day simple moving average is $45.87, demonstrating a positive trend in recent performance.

Earnings Report Highlights

On August 8, Brookfield Reinsurance announced its latest earnings results, reporting earnings per share of $0.08 for the quarter. The company has a net margin of 0.10% and a return on equity of 0.14%. Total revenue for the quarter amounted to $2.90 billion, reflecting the company’s ongoing operations in the insurance sector.

Recent Dividend Announcement

The company recently declared a quarterly dividend of $0.08 per share, which was paid on September 27. Shareholders who were on record as of September 12 received this payment, with the ex-dividend date also falling on that date. This translates to an annualized dividend of $0.32, yielding 0.59%. However, it’s notable that Brookfield Reinsurance's payout ratio is 110.34%, indicating that the company pays out more in dividends than it earns.

Institutional Interest

Several institutional investors have adjusted their positions in Brookfield Reinsurance. Mackenzie Financial Corp increased its stake by 52.7% during the second quarter, now holding 18,575 shares worth approximately $773,000 after acquiring an additional 6,410 shares. Cowen and Company LLC raised its holdings by 2.0%, bringing its total to 50,885 shares valued at about $2.12 million. Moreover, Triasima Portfolio Management grew its shares by 74.0%, owning 55,219 shares worth around $2.30 million after purchasing 23,488 shares recently.

Other notable moves include Bank of New York Mellon Corp acquiring a new stake valued at about $369,000 and the Swiss National Bank increasing its position by 7.6% in the first quarter, now possessing 15,600 shares worth $656,000. Overall, institutional investors and hedge funds collectively own 7.19% of Brookfield Reinsurance’s stock.

Company Overview

Brookfield Reinsurance Ltd. operates through its subsidiaries, providing various insurance and reinsurance services to customers in the United States, Canada, and other regions. The company has three primary segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT). The Direct Insurance segment covers a wide array of products, including various types of life insurance, annuities, casualty products, professional liability, and property and health insurance.

Key Considerations for Investors

Given current market conditions, potential investors may be wondering if now is a good time to invest in Brookfield Reinsurance. With a “hold” rating from analysts, it's valuable to consider other stocks being recommended as well. Market insights suggest looking beyond Brookfield Reinsurance toward other investment opportunities that might offer better returns.

stocks, dividends, earnings